Welcome to Jianke online pharmacy! Sign in Free registration
reminder:The pictures are the real photos of the original products taken by Jianke for reference only; In case of new packaging listing, there may be update lag, please take the physical object as the standard!
Baidu certification

Teggio capsule (Suli)

Unresectable locally advanced or metastatic gastric cancer. More role
App download minus 10 yuan
Common name:
Teggio capsule
Product No.:
S14200270497
Approval No.:
Gyzz h20100150 (inquired by the State Drug Administration)
Jianke price:
¥1360.00
Product specification:
20mg*28s 20mg*28s 25mg*28s
Manufacturer:
Qilu Pharmaceutical Co., Ltd
number        Quantity:
Add to list
Tips:
This product is a prescription drug. Please buy it with the prescription paper; Delivered by Jianke offline drugstore
 
(for assistance, please call400-086-5111
Jianke promises:
Genuine guarantee
Bank remittance / transfer online payment
Related classification
People who browse this product also browse
    Your recent history
      Wechat sweep: Jianke
      Health care doctor
      • Product introduction
      • instructions
      • Qualification certificate
      • Relevant information
      Product name Teggio capsule (Suli)
      Main raw materials This product is a compound preparation. Each capsule contains: 20mg specification: tegafur 20mg, gemcitabine 5.8mg, otilaxi potassium 19.6mg.
      Main role Unresectable locally advanced or metastatic gastric cancer.
      Product specification 20mg*28s
      Usage and dosage Teggio capsule combined with cisplatin for the treatment of patients with unresectable locally advanced or metastatic gastric cancer: Generally, the first dose for adults is determined according to the following table according to the body surface area. Usage: oral administration twice a day after morning and evening meals, continuous administration for 28 days and rest for 14 days, which is a treatment cycle. The drug was administered until the patient's condition worsened or could not be tolerated. Body surface area (M2) first dose (calculated by tegafur) < 1.25, 40mg each time ≥ 1.25 ~ < 1.5 50mg each time ≥ 1.5 60mg each time The dosage can be increased or decreased according to the patient's situation. The dosage of each administration increased or decreased in the order of four dose levels: 40mg, 50mg, 60mg and 75mg. If there are no safety problems such as abnormal laboratory tests (blood routine, liver and kidney function) and gastrointestinal symptoms caused by this drug, and the doctor judges that it is necessary to increase, a dose level can be added according to the above order, with the upper limit of 75mg / time. If reduction is required, it shall be reduced according to the dose level, and the lower limit is 40mg / time. Continuous oral administration for 21 days, rest for 14 days, intravenous drip of cisplatin 60mg / m2 on the 8th day of administration, as a treatment cycle. The drug was administered until the patient's condition worsened or could not be tolerated. (see the inner package manual for details)
      manufacturing enterprise Qilu Pharmaceutical Co., Ltd
      Jianke commitment
      • Genuine guarantee, formal invoice

        Jianke.com is an approved (B2C) Internet drug legitimate business enterprise in Guangdong Province. It signs a direct supply agreement with the manufacturer and can issue formal invoices for the purchased goods.

      • Private packaging, privacy protection

        When jianke.com packages and delivers goods, the appearance of the packing box only displays the necessary information for delivery, and the name of the purchased goods will not appear. The specific shopping list is in the package to protect the privacy of customers.

      • Efficient logistics and safe arrival

        All products of jianke.com adopt the door-to-door distribution mode of third-party logistics. They are delivered to the nearest warehouse according to your distribution address, so as to deliver them to you on time.

      • Three warehouses to ensure inventory

        Jianke.com has three warehouses in Guangzhou, Dongguan and Wuhan, equipped with first-class equipment, constant temperature and humidity to ensure drug quality. Specially assigned person to manage and ensure product inventory.

      [drug name] Teggio capsule (Suli)

      [common name] Teggio capsule

      [specification and model] 20mg*28s

      [manufacturer] Qilu Pharmaceutical Co., Ltd

      [drug type] Western medicine

      [approval No.] Gyzz h20100150

      [validity period] 24 months

      [functional indications] Unresectable locally advanced or metastatic gastric cancer.

      [usage and dosage] Teggio capsule combined with cisplatin for the treatment of patients with unresectable locally advanced or metastatic gastric cancer: Generally, the first dose for adults is determined according to the following table according to the body surface area. Usage: oral administration twice a day after morning and evening meals, continuous administration for 28 days and rest for 14 days, which is a treatment cycle. The drug was administered until the patient's condition worsened or could not be tolerated. Body surface area (M2) first dose (calculated by tegafur) < 1.25, 40mg each time ≥ 1.25 ~ < 1.5 50mg each time ≥ 1.5 60mg each time The dosage can be increased or decreased according to the patient's situation. The dosage of each administration increased or decreased in the order of four dose levels: 40mg, 50mg, 60mg and 75mg. If there are no safety problems such as abnormal laboratory tests (blood routine, liver and kidney function) and gastrointestinal symptoms caused by this drug, and the doctor judges that it is necessary to increase, a dose level can be added according to the above order, with the upper limit of 75mg / time. If reduction is required, it shall be reduced according to the dose level, and the lower limit is 40mg / time. Continuous oral administration for 21 days, rest for 14 days, intravenous drip of cisplatin 60mg / m2 on the 8th day of administration, as a treatment cycle. The drug was administered until the patient's condition worsened or could not be tolerated. (see the inner package manual for details)

      [adverse reactions] Not yet clear.

      [precautions] If other fluorouracil antitumor drugs or fluorocytosine antifungal drugs need to be taken after the withdrawal of teggio capsule, there must be a washout period of at least 7 days (see [drug interaction]) after the withdrawal of other fluorouracil antitumor drugs or fluorocytosine antifungal drugs, considering the impact of previous drugs, if teggio capsule is used, there must be an appropriate washout period (see [drug interaction]) [drug interaction]) It has been reported that fluorouracil drugs combined with antiviral drugs sollivdine or brovudine will cause serious hematopoietic dysfunction and may endanger the lives of patients. Therefore, do not use them in combination with sollivdine and its structural analogues. After sollivdine and its result analogues are stopped, considering the impact of previous drugs, at least 56 days must be allowed before using teggio capsule Days of washout (see drug interactions). Serious infectious diseases (septicemia) caused by myelosuppression have been reported. In case of death due to septic shock and disseminated intravascular coagulation, special attention should be paid to avoid the occurrence or aggravation of infection or bleeding tendency. Pregnant women should consider the potential gonadal effects when using this product. This product may cause or aggravate interstitial pneumonia, and severe cases can be fatal. Therefore, before giving teggio capsule, the patient should be examined to determine whether she has Interstitial pneumonia. During administration, the patient should be closely observed for breathing, cough, fever and other symptoms, and chest X-ray examination should be carried out. If any abnormality is found, stop the drug immediately and take corresponding measures. Patients with non-small cell lung cancer are more likely to develop interstitial pneumonia and other lung diseases than other patients. Please read the instructions carefully and follow the doctor's instructions.

      [taboo] 1. Patients with a history of severe allergy to the ingredients of this product. 2. Patients with severe myelosuppression (may lead to deterioration of symptoms). 3. Patients with severe renal dysfunction. 4. Patients with severe liver dysfunction. 5. Patients who are using other fluorouracil antitumor drugs, including combination chemotherapy with these drugs. 6. Patients who are using fluorocytosine.

      [listing Permit Holder] Qilu Pharmaceutical Co., Ltd

      [packaging unit] box

      [main ingredients] This product is a compound preparation. Each capsule contains: 20mg specification: tegafur 20mg, gemcitabine 5.8mg, otilaxi potassium 19.6mg.

      [character] This product is a hard capsule with white or quasi white particles or powder.

      [applicable population] unlimited

      [medication for pregnant and lactating women] 1. This product is forbidden for pregnant women and women of childbearing age. 2. Lactating women should stop lactation if they need drugs.

      [medication for children] The safety of this product for infants, newborns, infants and children with low birth weight has not been established.

      [medication for elderly patients] Generally, most elderly people have low physiological function. Observe the patient's state and use this product with caution.

      [storage] Shading, sealing, storage below 25 ℃.

      Praise degree

      zero%

        reminder

        Dear customer:

        In case of emergency, please call the ordering hotline400-086-5111Consult a health care professional pharmacist.

        Teggio capsule (Suli)

        ¥1360.00

        reminder

        To ensure your privacy, please enter the verification code and click "confirm callback". Our customer service staff will call back the phone number you entered later!

        Please enter the correct verification code!
        Loding...
        Can't see clearly. Change one

        Dear customer:

        Your callback failed this time. Please re-enter the verification code to try. Thank you!